Midwest Trust’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Midwest Trust's IBB Position: Q2 2026 in Review
Midwest Trust reduced its iShares Biotechnology ETF (IBB) stake by 9.6% in Q2 2026, selling an estimated $81K and leaving 4,423 shares worth $841K. The position accounts for 0.01% of the portfolio, ranked #374.
Midwest Trust first reported a position in IBB in Q2 2025 and has held it in 5 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Midwest Trust held 4,423 shares of iShares Biotechnology ETF worth $841K as of Q2 2026.
- Midwest Trust sold 471 iShares Biotechnology ETF shares in Q2 2026, an estimated $81K.
- iShares Biotechnology ETF made up 0.01% of Midwest Trust's portfolio in Q2 2026, its #374 holding.
- Midwest Trust first reported a position in iShares Biotechnology ETF in Q2 2025 and has held it in 5 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.